Alpha 1-antitrypsin. Hope on the horizon for emphysema sufferers? (Q45888068)

17 December 2017

review article

1 reference

title

Alpha 1-antitrypsin. Hope on the horizon for emphysema sufferers? (English)

1 reference

17 December 2017

1 reference

M Schwaiblmair

1

1 reference

17 December 2017

C Vogelmeier

series ordinal

2

1 reference

17 December 2017

language of work or name

1 reference

1 June 1998

1 reference

17 December 2017

published in

Drugs & Aging

1 reference

17 December 2017

volume

12

1 reference

17 December 2017

page(s)

429-440

1 reference

17 December 2017

issue

6

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.2165/00002512-199812060-00002

exact match

0 references

cites work

Alpha-1-antitrypsin augmentation therapy for alpha-1-antitrypsin deficiency

1 reference

12 December 2020

Emphysema: the first two centuries--and beyond. A historical overview, with suggestions for future research: Part 2

1 reference

12 December 2020

Implications of the three-dimensional structure of alpha 1-antitrypsin for structure and function of serpins

1 reference

12 December 2020

The role of cardiopulmonary exercise testing in lung and heart-lung transplantation.

1 reference

12 December 2020

Evaluation of elastase and antielastase balance in patients with chronic bronchitis and pulmonary emphysema

1 reference

12 December 2020

Aspects of treatment in alpha 1-antitrypsin deficiency: insights derived from a Swedish PiZZ series

1 reference

12 December 2020

Guidelines for the approach to the patient with severe hereditary alpha-1-antitrypsin deficiency. American Thoracic Society

1 reference

12 December 2020

Anti-neutrophil-elastase defenses of the lower respiratory tract in alpha 1-antitrypsin deficiency directly augmented with an aerosol of alpha 1-antitrypsin

1 reference

12 December 2020

Kinetic and Chemical Evidence for the Inability of Oxidized α1-Proteinase Inhibitor to Protect Lung Elastin from Elastolytic Degradation

1 reference

12 December 2020

Alpha 1-antitrypsin deficiency: the radiological features of pulmonary emphysema in subjects of Pi type Z and Pi type SZ: a survey by the British Thoracic Association

1 reference

12 December 2020

Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study

1 reference

12 December 2020

Amino acid substitution Glu→Lys in α1-antitrypsin PiZ

1 reference

12 December 2020

Inhibition of elastase and other serine proteases by heterocyclic acylating agents

1 reference

12 December 2020

Alpha-1-antitrypsin replacement therapy: will its efficacy ever be proved?

1 reference

12 December 2020

Alpha 1 antitrypsin deficiency: the clinical and physiological features of pulmonary emphysema in subjects homozygous for Pi type Z. A survey by the British Thoracic Association

1 reference

12 December 2020

The pharmacology and toxicology of three new biologic agents used in pulmonary medicine.

1 reference

12 December 2020

The oxidative inactivation of human alpha-1-proteinase inhibitor. Further evidence for methionine at the reactive center

1 reference

12 December 2020

The alpha 1-antitrypsin gene and its deficiency states

1 reference

12 December 2020

The balance of lung connective tissue elements in elastase-induced emphysema

1 reference

12 December 2020

Evaluation of tamoxifen as a therapy to augment alpha-1-antitrypsin concentrations in Z homozygous alpha-1-antitrypsin-deficient subjects

1 reference

12 December 2020

Expression of human alpha 1-antitrypsin in dogs after autologous transplantation of retroviral transduced hepatocytes

1 reference

12 December 2020

Adenovirus-mediated in vivo gene transfer and expression in normal rat liver

1 reference

12 December 2020

Synthetic inhibitors of elastase

1 reference

12 December 2020

Respiratory mechanics in hamsters following treatment with endotracrael elastase or collagenase

1 reference

12 December 2020

Clinical implications of gene therapy for alpha 1-antitrypsin deficiency

1 reference

12 December 2020

Highly variable clinical course in severe alpha 1-antitrypsin deficiency--use of polymerase chain reaction for the detection of rare deficiency alleles

1 reference

12 December 2020

alpha1-antitrypsin deficiency (first of two parts).

1 reference

12 December 2020

Oxidants spontaneously released by alveolar macrophages of cigarette smokers can inactivate the active site of alpha 1-antitrypsin, rendering it ineffective as an inhibitor of neutrophil elastase

1 reference

12 December 2020

Experimental emphysema induced with purified human neutrophil elastase: tissue localization of the instilled protease

1 reference

12 December 2020

Comparison of outcomes of double and single lung transplantation for obstructive lung disease. The Toronto Lung Transplant Group

1 reference

12 December 2020

Use of a highly purified alpha 1-antitrypsin standard to establish ranges for the common normal and deficient alpha 1-antitrypsin phenotypes

1 reference

12 December 2020

The induction of emphysema with elastase. II. Changes in connective tissue

1 reference

12 December 2020

A matched-pair study of the leukocyte elastase-like activity in normal persons and in emphysematous patients with and without alpha 1-antitrypsin deficiency

1 reference

12 December 2020

Interrelationships between neutrophil elastase, serum alpha, -antitrypsin, lung function and chest radiography in patients with chronic airflow obstruction

1 reference

12 December 2020

Molecular abnormality of human alpha1-antitrypsin variant (Pi-ZZ) associated with plasma activity deficiency

1 reference

12 December 2020

Selection and evaluation of recipients for heart-lung and lung transplantation

1 reference

12 December 2020

Proteinase-3 (PR-3): a polymorphonuclear leukocyte serine proteinase

1 reference

12 December 2020

The Washington University-Barnes Hospital experience with lung transplantation. Washington University Lung Transplantation Group

1 reference

12 December 2020

Replacement therapy in alpha 1-antitrypsin deficiency

1 reference

12 December 2020

Clinical features and history of the destructive lung disease associated with alpha-1-antitrypsin deficiency of adults with pulmonary symptoms.

1 reference

12 December 2020

Structure and variation of human alpha 1-antitrypsin

1 reference

12 December 2020

Antielastases of the human alveolar structures. Implications for the protease-antiprotease theory of emphysema

1 reference

12 December 2020

A family study of the variability of pulmonary function in alpha 1-antitrypsin deficiency. Quantitative phenotypes

1 reference

12 December 2020

Structural basis for serpin inhibitor activity

1 reference

12 December 2020

Human plasma proteinase inhibitors

1 reference

12 December 2020

Molecular basis of alpha-1-antitrypsin deficiency

1 reference

12 December 2020

Cost-effectiveness of alpha-1 antitrypsin replacement therapy in treatment of congenital chronic obstructive pulmonary disease

1 reference

12 December 2020

A new method for determination of alpha-1-antitrypsin phenotypes using isoelectric focusing on polyacrylamide gel slabs

1 reference

12 December 2020

Natural History and Life Expectancy in Severe Alpha1-Antitrypsin Deficiency, Pi Z

1 reference

12 December 2020

Characterization of α1-Antitrypsin in the Inclusion Bodies from the Liver in α1-Antitrypsin Deficiency

1 reference

12 December 2020

PULMONARY EMPHYSEMA AND ALPHA1-ANTITRYPSIN DEFICIENCY.

1 reference

12 December 2020

Chemical, biochemical, pharmacokinetic, and biological properties of L-680,833: a potent, orally active monocyclic beta-lactam inhibitor of human polymorphonuclear leukocyte elastase

1 reference

12 December 2020

Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force

1 reference

12 December 2020

Inhibitory conformation of the reactive loop of alpha 1-antitrypsin

1 reference

12 December 2020

Synthetic elastase inhibitors: prospects for use in the treatment of emphysema

1 reference

12 December 2020

Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Report of the Medical Research Council Working Party

1 reference

12 December 2020

Elastases and emphysema. Current assessment of the protease-antiprotease hypothesis

1 reference

12 December 2020

Biochemical efficacy and safety of monthly augmentation therapy for alpha 1-antitrypsin deficiency

1 reference

12 December 2020

Emphysema and bronchial secretory cell metaplasia induced in hamsters by human neutrophil products

1 reference

12 December 2020

Clinical pharmacokinetics of alpha 1-antitrypsin in homozygous PiZ deficient patients

1 reference

12 December 2020

The "horse-racing effect" and predicting decline in forced expiratory volume in one second from screening spirometry

1 reference

12 December 2020

Early and long-term functional outcomes following lung volume reduction surgery

1 reference

12 December 2020

Exercise performance after lung transplantation

1 reference

12 December 2020

Neutrophil elastase and pulmonary function in subjects with intermediate alpha1-antitrypsin deficiency (MZ phenotype)

1 reference

12 December 2020

Alpha 1-antitrypsin alleles in patients with pulmonary emphysema, detected by DNA amplification (PCR) and oligonucleotide probes

1 reference

12 December 2020

Intravenous recombinant secretory leukoprotease inhibitor augments antineutrophil elastase defense

1 reference

12 December 2020

The human alpha 1-antitrypsin gene is transcribed from two different promoters in macrophages and hepatocytes

1 reference

12 December 2020

Studies in alpha 1-antitrypsin deficiency.

1 reference

12 December 2020

Lung transplantation for alpha 1-antitrypsin deficiency emphysema

1 reference

12 December 2020

Single lung transplantation for severe chronic obstructive pulmonary disease. Washington University Lung Transplant Group.

1 reference

12 December 2020

Studies on the oligosaccharide chains of human alpha 1-protease inhibitor. I. Isolation of glycopeptides

1 reference

12 December 2020

Anti-neutrophil elastase defense of the normal human respiratory epithelial surface provided by the secretory leukoprotease inhibitor

1 reference

12 December 2020

Replacement therapy of alpha 1-antitrypsin deficiency. Reversal of protease-antiprotease imbalance within the alveolar structures of PiZ subjects

1 reference

12 December 2020

The serpin superfamily of proteinase inhibitors: structure, function, and regulation

1 reference

12 December 2020

The electrophoretic α1-globulin pattern of serum in α1-antitrypsin deficiency. 1963.

1 reference

12 December 2020

Orthotopic liver transplantation for alpha-1-antitrypsin deficiency: an experience in 29 children and ten adults.

1 reference

12 December 2020

Clonal gene therapy: transplanted mouse fibroblast clones express human alpha 1-antitrypsin gene in vivo

1 reference

12 December 2020

Smoking, lung function, and alpha 1-antitrypsin deficiency.

1 reference

12 December 2020

Decline in FEV1 among patients with severe hereditary alpha 1-antitrypsin deficiency type PiZ.

1 reference

12 December 2020

Survival in relation to lung function and smoking cessation in patients with severe hereditary alpha 1-antitrypsin deficiency

1 reference

12 December 2020

The Registry of the International Society for Heart and Lung Transplantation: twelfth official report--1995.

1 reference

12 December 2020

Natural history of alpha-1-protease inhibitor deficiency

1 reference

12 December 2020

Purification of alpha-1-proteinase inhibitor. Preparation and properties of a therapeutic concentrate

1 reference

12 December 2020

Adenovirus-mediated transfer of a recombinant alpha 1-antitrypsin gene to the lung epithelium in vivo

1 reference

12 December 2020

Alpha1-antitrypsin and its deficiency

1 reference

12 December 2020

Alpha 1-antitrypsin deficiency, emphysema, and liver disease. Genetic basis and strategies for therapy

1 reference

12 December 2020

Long-term augmentation therapy in twenty patients with severe alpha-1-antitrypsin deficiency--three-year follow-up.

1 reference

12 December 2020

Metabolism of Intact and Desialylated α1-Antitrypsin

1 reference

12 December 2020

Replacement therapy for hereditary alpha1-antitrypsin deficiency. A program for long-term administration

1 reference

12 December 2020

Cephalosporin antibiotics can be modified to inhibit human leukocyte elastase

1 reference

12 December 2020

Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society

1 reference

12 December 2020

Alpha1-antitrypsin deficiency (second of two parts).

1 reference

12 December 2020

Pulmonary function in single lung transplantation for chronic obstructive pulmonary disease

1 reference

12 December 2020

Unilateral lung transplantation in end-stage pulmonary emphysema

1 reference

12 December 2020

Biologic characterization of ICI 200,880 and ICI 200,355, novel inhibitors of human neutrophil elastase

1 reference

12 December 2020

Evaluation of recombinant DNA-directed E.coli produced alpha 1-antitrypsin as an anti-neutrophil elastase for potential use as replacement therapy of alpha 1-antitrypsin deficiency

1 reference

12 December 2020

Contribution of secretory leukocyte proteinase inhibitor to the antiprotease defense system of the peripheral lung: effect of ozone-induced acute inflammation.

1 reference

12 December 2020

Decline in pulmonary function in patients with alpha 1-antitrypsin deficiency.

1 reference

12 December 2020

Interactions of neutrophil elastase, serum trypsin inhibitory activity, and smoking history as risk factors for chronic obstructive pulmonary disease in patients with MM, MZ, and ZZ phenotypes for alpha-antitrypsin

1 reference

12 December 2020

New insights into the structural basis of alpha 1-antitrypsin deficiency

1 reference

12 December 2020

The induction of pulmonary emphysema with human leukocyte elastase

1 reference

12 December 2020

Alpha 1-antitrypsin deficiency. A conformational disease

1 reference

12 December 2020

Double-lung transplant for advanced chronic obstructive lung disease

1 reference

12 December 2020

Human alpha 1-proteinase inhibitor. Crystal structure analysis of two crystal modifications, molecular model and preliminary analysis of the implications for function

1 reference

12 December 2020

Technique of successful clinical double-lung transplantation

1 reference

12 December 2020

Variability of pulmonary function in alpha-1-antitrypsin deficiency: clinical correlates.

1 reference

12 December 2020

α-1-Anti-trypsin, an inhibitor of renin

1 reference

12 December 2020

Augmentation of lung antineutrophil elastase capacity with recombinant human alpha-1-antitrypsin

1 reference

12 December 2020

Evaluation and preoperative management of lung volume reduction surgery candidates

1 reference

12 December 2020

Clinical features and molecular characteristics of alpha 1-antitrypsin deficiency.

1 reference

12 December 2020

Medium term functional results of single-lung transplantation for endstage obstructive lung disease

1 reference

12 December 2020

Identification and Characteristics of the Common Alpha1-Antitrypsin Phenotypes

1 reference

12 December 2020

Biochemical and biological properties of an alpha 1-antitrypsin concentrate

1 reference

12 December 2020

Functional results of single-lung transplantation for chronic obstructive lung disease

1 reference

12 December 2020

Evaluation of the rapid plasma elimination of recombinant alpha 1-proteinase inhibitor: synthesis of polyethylene glycol conjugates with improved therapeutic potential.

1 reference

12 December 2020

The natural history of air-flow obstruction in PiZ emphysema. Report of an NHLBI workshop

1 reference

12 December 2020

Recombinant DNA-produced alpha 1-antitrypsin administered by aerosol augments lower respiratory tract antineutrophil elastase defenses in individuals with alpha 1-antitrypsin deficiency

1 reference

12 December 2020

Inhibitors of leukocyte elastase and leukocyte cathepsin G. Agents for the treatment of emphysema and related ailments

1 reference

12 December 2020

Complete sequence of the cDNA for human .alpha.1-antitrypsin and the gene for the S variant

1 reference

12 December 2020

Replacement therapy for alpha-1-protease inhibitor deficiency in PiZ subjects with chronic obstructive lung disease

1 reference

12 December 2020

Evaluation and research in lung volume reduction surgery

1 reference

12 December 2020

Mobile reactive centre of serpins and the control of thrombosis

1 reference

12 December 2020

Long term effect on lung function of alpha 1-protease inhibitor substitution therapy in COPD patients with Pi ZZ phenotype.

1 reference

12 December 2020

Mutation of antitrypsin to antithrombin. alpha 1-antitrypsin Pittsburgh (358 Met leads to Arg), a fatal bleeding disorder

1 reference

12 December 2020

Neutrophil lysosomal elastase activity in normal subjects and in patients with chronic obstructive pulmonary disease

1 reference

12 December 2020

Replacement therapy for alpha 1-antitrypsin deficiency associated with emphysema

1 reference

12 December 2020

The proteinase-antiproteinase balance in alpha-1-proteinase inhibitor-deficient lung transplant recipients

1 reference

12 December 2020

Pulmonary deposition and clearance of aerosolized alpha-1-proteinase inhibitor administered to dogs and to sheep

1 reference

12 December 2020

Evaluation of danazol therapy for patients with PiZZ alpha-1-antitrypsin deficiency

1 reference

12 December 2020

Alpha-1-protease inhibitor in bronchial asthma: phenotypes and biochemical characteristics

1 reference

12 December 2020

Does alpha1-antitrypsin augmentation therapy slow the annual decline in FEV1 in patients with severe hereditary alpha1-antitrypsin deficiency? Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL) alpha1-AT study group.

1 reference

12 December 2020

Intraperitoneal in vivo gene therapy to deliver alpha 1-antitrypsin to the systemic circulation

1 reference

12 December 2020

Alpha1-antitrypsin and alpha2-macroglobulin. Interactions with human neutrophil collagenase and elastase

1 reference

12 December 2020

Kinetics of association of serine proteinases with native and oxidized alpha-1-proteinase inhibitor and alpha-1-antichymotrypsin.

1 reference

12 December 2020

The alpha 1-antitrypsin gene and its mutations. Clinical consequences and strategies for therapy

1 reference

12 December 2020

Animal models of emphysema

1 reference

12 December 2020

Long-term treatment of alpha1-antitrypsin deficiency-related pulmonary emphysema with human alpha1-antitrypsin. Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL)-alpha1-AT-study group

1 reference

12 December 2020

10.2165/00002512-199812060-00002

Identifiers

DOI

1 reference

17 December 2017

Dimensions Publication ID

0 references

1 reference

17 December 2017